Back to Search
Start Over
The effects of resveratrol treatment on caveolin-3 expression and Na+/K+ ATPase activity in rats with isoproterenol-induced myocardial injury
- Source :
- Northern Clinics of Istanbul, İstanbul Kuzey Klinikleri, Vol 7, Iss 4, Pp 313-320 (2020)
- Publication Year :
- 2020
- Publisher :
- Kare Publishing, 2020.
-
Abstract
- Objective The present study aims to investigate the therapeutic effects of resveratrol (RES) on isoproterenol (ISO) induced myocardial injury rat model. Methods Catecholamine-induced heart damage was induced by ISO treatment for 30 days. The rats were divided into four groups as follows: the control group received saline, the ISO group received 5.0 mg/kg ISO, the RES group received 10 mg/kg RES, and the ISO-RES group received 10 mg/kg RES and 5 mg/kg ISO treatments for 30 days. Following echocardiographic measurements and body weight recorded, the rats were decapitated. Plasma and cardiac tissue samples obtained by decapitation were analyzed using biochemical, histopathological, molecular and immunohistochemical methods. Results In the ISO group, Na+/K+ ATPase activity and ATP content, GSH, and caveolin-3 levels were low. LDH, CK and lysosomal enzyme activities, MDA level, and MPO activity were found to be high. It was determined that GSH and MDA levels and MPO, Na+/K+ ATPase activity, ATP content caveolin-3 levels changes that arose from ISO treatment were suppressed by RES treatment. Conclusion RES treatment has ameliorated all the functional and biochemical parameters. The results obtained in this study suggest that RES is a promising supplement against catecholamine exposure as it improves antioxidant defense mechanisms in the heart. In the light of above-mentioned data, RES can be assumed as a promising agent in ameliorating the oxidative injury of the myocardium.
- Subjects :
- 0301 basic medicine
Antioxidant
INDUCED CARDIOTOXICITY
medicine.medical_treatment
lysosomal enzymes
lcsh:Medicine
heart failure
030204 cardiovascular system & hematology
Resveratrol
Pharmacology
resveratrol
MECHANISMS
PROTECTS
03 medical and health sciences
chemistry.chemical_compound
Caveolin-3
0302 clinical medicine
isoproterenol
medicine
Saline
chemistry.chemical_classification
lcsh:R5-920
business.industry
NECROSIS
lcsh:R
MYELOPEROXIDASE
Glutathione
medicine.disease
Caveolin 3
030104 developmental biology
Enzyme
chemistry
Heart failure
ACID
Catecholamine
HEART
Original Article
lcsh:Medicine (General)
business
INFARCTION
medicine.drug
Subjects
Details
- Language :
- English
- ISSN :
- 25364553 and 21484902
- Volume :
- 7
- Issue :
- 4
- Database :
- OpenAIRE
- Journal :
- Northern Clinics of Istanbul
- Accession number :
- edsair.doi.dedup.....1f8df30e9b9ac3c70e6047fd3a25786f